Share
5,496 Posts.
lightbulb Created with Sketch. 35
clock Created with Sketch. 31/05/16
21:15
Share
Originally posted by cat dog
↑
Hi all, I attended the Investor Presentation in Adelaide tonight (young guy in navy suit sitting two rows back on the left). Had to leave straight after but would have been good to stick around for a bit and meet everyone. Atmosphere Glyn spoke first and didn't really say much but painted a picture of the company’s long journey to get to where they are today. P&G SKII Eye Wand and Wave II Interesting fact from Jeff, SKII consumers spend on average $500 per month on cosmetics. Jeff also mentioned that the soft launch of the SKII eye wand added $7m to SKII's bottom line. SKII DCE Jeff mentioned that there are 2 products in the pipeline with SKII for the DCE technology. Olay Eye Wand We know that P&G have committed to the eye wand for a second P&G brand. Glyn wouldn't say which one but mentioned it was a much bigger brand than SKII. Olay Wave II The Olay Wave II device hasn't been committed but it doesn't sounds far off. Gillette When talking about the possibilities of incorporating OBJ tech into shaving products, Jeff let another big word slip. This time it was the word "Gillette" and the mention of 3.5 million shavers sold per day. Coty Inc They're still working closely with Coty on the powered products. Jeff mentioned that the recent acquisition of multiple brands by Coty was expected to be finalised in October this year. P&G brands are part of this acquisition and work with P&G on these brands is moving across to Coty. Reckitt Benckiser Magnetic micro array for nurofen gel tube is currently under development with Reckitt Benckiser. Not commercialised yet but Jeff was nodding his head and basically said it was going to be before Glyn jumped in and said hopefully. Bodyguard Glyn seemed very sure that Bodyguard would be commercialised by multiple brands for different purposes. A direct quote from Glyn when asked about time frames was "amazed if it stays still for very long". Voltaren (Novartis) Voltaren was the NSAID we smashed out of the park in the Bodyguard double blind trial. Glyn mentioned that they've now come to OBJ for possible product development. I think that is huge that our product was able to beat the competition to the point that they'd rather join us than fight us. Big tick!
Expand
Last AGM I heard P&G wanted exclusivitity with DCE, looks like they may get it. Its interesting to see how P&G wants DCE as well even though I think it was originally developed for other companies. Thanks for the update cat.
(20min delay)